Skip to main content

Theravance Biopharma, Inc.

TBPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583107

In the last 90 days, Theravance Biopharma, Inc. insiders filed 0 open-market purchases and 3 sales; 179 institutions reported holding it in 13F filings for Q2 2026, worth $817.5M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Theravance Biopharma, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
123
+10 vs. Q2 2022
Shares held
64.1M
−159.8K (−0.2%) vs. Q2 2022
Total value
$649.8M
+$67.8M (+11.7%) vs. Q2 2022
New holders
23
45 more added
Sold out
13
28 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting TBPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 123 institutions
Q1 2021: 107 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 116 institutionsQ1 2022: 121 institutionsQ2 2022: 113 institutionsQ3 2022: 123 institutionsQ4 2022: 119 institutionsQ1 2023: 114 institutionsQ2 2023: 119 institutionsQ3 2023: 115 institutionsQ4 2023: 118 institutionsQ1 2024: 121 institutionsQ2 2024: 132 institutionsQ3 2024: 119 institutionsQ4 2024: 128 institutionsQ1 2025: 132 institutionsQ2 2025: 135 institutionsQ3 2025: 161 institutionsQ4 2025: 169 institutionsQ1 2026: 173 institutionsQ2 2026: 179 institutions
Value heldQ3 2022: $649.8M
Q1 2021: $1.09BQ2 2021: $883.1MQ3 2021: $448.8MQ4 2021: $655.6MQ1 2022: $602.5MQ2 2022: $582.0MQ3 2022: $649.8MQ4 2022: $696.1MQ1 2023: $652.6MQ2 2023: $546.3MQ3 2023: $438.5MQ4 2023: $548.7MQ1 2024: $430.6MQ2 2024: $399.5MQ3 2024: $368.9MQ4 2024: $422.4MQ1 2025: $400.9MQ2 2025: $512.2MQ3 2025: $706.3MQ4 2025: $927.2MQ1 2026: $814.2MQ2 2026: $817.5M
Institutions holding TBPH and their total value by quarter
QuarterHoldersValue
Q2 2026179$817.5M
Q1 2026173$814.2M
Q4 2025169$927.2M
Q3 2025161$706.3M
Q2 2025135$512.2M
Q1 2025132$400.9M
Q4 2024128$422.4M
Q3 2024119$368.9M
Q2 2024132$399.5M
Q1 2024121$430.6M
Q4 2023118$548.7M
Q3 2023115$438.5M
Q2 2023119$546.3M
Q1 2023114$652.6M
Q4 2022119$696.1M
Q3 2022123$649.8M
Q2 2022113$582.0M
Q1 2022121$602.5M
Q4 2021116$655.6M
Q3 2021119$448.8M
Q2 2021109$883.1M
Q1 2021107$1.09B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Theravance Biopharma, Inc.; share changes are against Q2 2022.

Institutions holding TBPH in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Pictet Asset Management SA370,379$3.76M0.01%+108,952+41.7%Added
Charles Schwab Investment Management Inc524,916$5.32M0.00%+21,439+4.3%Added
Norges Bank545,427$5.53M0.00%00.0%Unchanged
Northern Trust Corp598,303$6.07M0.00%+3,069+0.5%Added
Morgan Stanley598,665$6.07M0.00%+205,080+52.1%Added
Goldman Sachs Group Inc622,859$6.32M0.00%+39,830+6.8%Added
Millennium Management LLC650,558$6.60M0.01%+650,558New
Two Sigma Investments, LP652,870$6.62M0.02%+652,870New
Two Sigma Advisers, LP696,600$7.06M0.02%+696,600New
Jacobs Levy Equity Management, Inc827,906$8.39M0.07%−31,700−3.7%Reduced
Bank of America Corp921,281$9.34M0.00%+245,648+36.4%Added
Geode Capital Management, LLC1,079,087$10.9M0.00%+51,423+5.0%Added
Chescapmanager LLC1,160,503$11.8M3.58%00.0%Unchanged
State Street Corp1,484,759$15.1M0.00%−10,287−0.7%Reduced
D. E. Shaw & Co., Inc.1,587,198$16.1M0.03%+206,801+15.0%Added
Park West Asset Management LLC1,919,354$19.5M1.54%−1,253,900−39.5%Reduced
Newtyn Management, LLC2,495,860$25.3M5.56%+458,035+22.5%Added
FMR LLC2,540,287$25.8M0.00%−158,063−5.9%Reduced
BlackRock Inc.5,107,527$51.8M0.00%+84,787+1.7%Added
Vanguard Group Inc6,006,133$60.9M0.00%−538,673−8.2%Reduced
Madison Avenue Partners, LP7,012,226$71.1M15.25%−257,358−3.5%Reduced
Weiss Asset Management LP7,457,060$75.6M1.98%+1,219,622+19.6%Added
Baupost Group LLCSuperinvestorBaupost Group13,419,226$136.1M2.35%00.0%Unchanged
OrbiMed Advisors LLC0$00.00%−1,370,250−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−252,845−100.0%Sold out
First Pacific Advisors, LP0$00.00%−176,539−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−114,646−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−105,900−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−103,280−100.0%Sold out
Walleye Capital LLC0$00.00%−82,758−100.0%Sold out
Zazove Associates LLC0$00.00%−59,599−100.0%Sold out
King Wealth0$00.00%−45,000−100.0%Sold out
Walleye Trading LLC0$00.00%−14,475−100.0%Sold out
State of Wyoming0$00.00%−4,275−100.0%Sold out
Captrust Financial Advisors0$00.00%−91−100.0%Sold out
Elequin Capital LP0$00.00%−7−100.0%Sold out